BSE Live
Oct 08, 16:01Prev. Close
1154.65
Open Price
1146.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 08, 15:40Prev. Close
1141.80
Open Price
1147.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1129.90 (28)
Key Financial Ratios of SMS Lifesciences India (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 30.26 | 55.02 | 21.50 | 42.81 | -1.85 | |
Diluted EPS (Rs.) | 30.26 | 55.02 | 21.50 | 42.81 | -1.85 | |
Cash EPS (Rs.) | 54.22 | 74.10 | 40.37 | 18,497.70 | -1.85 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 374.61 | 347.23 | 292.42 | 81,838.70 | -8.21 | |
Book Value [InclRevalReserve]/Share (Rs.) | 374.61 | 347.23 | 292.42 | 81,838.70 | -8.21 | |
Dividend / Share(Rs.) | 0.00 | 1.50 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 849.81 | 1,138.33 | 704.49 | 215,893.80 | 0.00 | |
PBDIT/Share (Rs.) | 84.91 | 115.74 | 53.85 | 30,181.30 | -1.85 | |
PBIT/Share (Rs.) | 60.95 | 96.65 | 34.98 | 24,626.80 | -1.85 | |
PBT/Share (Rs.) | 44.12 | 78.58 | 21.16 | 18,462.10 | -1.85 | |
Net Profit/Share (Rs.) | 30.26 | 55.02 | 21.50 | 12,943.20 | -1.85 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 9.99 | 10.16 | 7.64 | 13.97 | 0.00 | |
PBIT Margin (%) | 7.17 | 8.49 | 4.96 | 11.40 | 0.00 | |
PBT Margin (%) | 5.19 | 6.90 | 3.00 | 8.55 | 0.00 | |
Net Profit Margin (%) | 3.56 | 4.83 | 3.05 | 5.99 | 0.00 | |
Return on Networth / Equity (%) | 8.07 | 15.84 | 7.35 | 15.81 | 0.00 | |
Return on Capital Employed (%) | 12.35 | 20.52 | 9.37 | 22.96 | 22.53 | |
Return on Assets (%) | 3.99 | 6.63 | 3.68 | 7.38 | -116.90 | |
Total Debt/Equity (X) | 0.39 | 0.38 | 0.24 | 0.24 | -0.37 | |
Asset Turnover Ratio (%) | 112.22 | 137.27 | 120.56 | 123.19 | 0.00 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.27 | 1.20 | 1.39 | 1.38 | 0.16 | |
Quick Ratio (X) | 0.50 | 0.51 | 0.62 | 0.74 | 0.16 | |
Inventory Turnover Ratio (X) | 4.21 | 4.66 | 4.32 | 4.93 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 95.23 | 204.36 | 134.67 | 0.00 | 0.00 | |
EV/Net Operating Revenue (X) | 0.37 | 0.59 | 0.63 | 0.00 | 0.00 | |
EV/EBITDA (X) | 3.71 | 5.84 | 8.27 | 0.00 | 0.00 | |
MarketCap/Net Operating Revenue (X) | 0.21 | 0.48 | 0.54 | 0.00 | 0.00 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 0.47 | 1.59 | 1.29 | 0.00 | 0.00 | |
Price/Net Operating Revenue | 0.21 | 0.48 | 0.54 | 0.00 | 0.00 | |
Earnings Yield | 0.17 | 0.10 | 0.06 | 0.00 | 0.00 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017